CVRx Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CVRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Mar 26	SellUS$61,349	Kevin Hykes	Individual	7,763	US$7.90
02 Mar 26	SellUS$13,781	Jared Oasheim	Individual	1,744	US$7.90
02 Mar 26	SellUS$10,146	Paul Verrastro	Individual	1,284	US$7.90
02 Mar 26	SellUS$31,326	Robert John	Individual	3,964	US$7.90
02 Mar 26	SellUS$9,973	Philip Adamson	Individual	1,262	US$7.90
20 Feb 26	BuyUS$297,592	Treo Ventures, LLC	Company	46,800	US$6.36
18 Feb 26	BuyUS$2,785	Mudit Jain	Individual	600	US$4.64
26 Nov 25	SellUS$224,040	Johnson & Johnson Innovation - JJDC, Inc.	Company	22,337	US$10.03
24 Nov 25	SellUS$27,132	Johnson & Johnson Innovation - JJDC, Inc.	Company	2,700	US$10.06
12 Nov 25	SellUS$10,000	Johnson & Johnson Innovation - JJDC, Inc.	Company	1,000	US$10.00
07 Nov 25	SellUS$536,310	Johnson & Johnson Innovation - JJDC, Inc.	Company	52,532	US$10.21

Insider Trading Volume

Insider Buying: CVRX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CVRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	185,626	0.7%
General Public	7,474,894	28.2%
VC/PE Firms	7,961,078	30%
Institutions	10,914,346	41.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.2%	Johnson & Johnson Innovation - JJDC, Inc.	4,024,861	US$24.6m	0%	3.44%
7.64%	New Enterprise Associates, Inc.	2,026,083	US$12.4m	0%	0.78%
7.2%	Vensana Capital Management, LLC	1,910,134	US$11.7m	0%	no data
4.63%	Gilde Healthcare Partners BV	1,229,022	US$7.5m	0%	8.59%
3.87%	BlackRock, Inc.	1,026,559	US$6.3m	-3.25%	no data
3.8%	GSK Equity Investments, Limited	1,007,583	US$6.2m	0%	0.61%
3.69%	Treo Ventures, LLC	980,183	US$6.0m	5.01%	no data
3.43%	Vanguard Capital Management, LLC	911,310	US$5.6m	0%	no data
2.66%	Royal Bank of Canada	706,950	US$4.3m	6,560%	no data
2.38%	Balyasny Asset Management L.P.	630,812	US$3.9m	-22.6%	0.01%
2.16%	Silvercrest Asset Management Group LLC	572,021	US$3.5m	-9.87%	0.02%
1.62%	Parkman Healthcare Partners LLC	429,507	US$2.6m	3.99%	0.27%
1.61%	Geode Capital Management, LLC	427,072	US$2.6m	5.72%	no data
1.32%	State Street Global Advisors, Inc.	350,548	US$2.1m	12.5%	no data
0.87%	FourWorld Capital Management LLC	231,996	US$1.4m	28.9%	0.54%
0.74%	Tudor Investment Corporation	197,340	US$1.2m	25.5%	0.01%
0.57%	Northern Trust Global Investments	150,123	US$917.2k	8.94%	no data
0.51%	Morgan Stanley	135,097	US$825.4k	-64%	no data
0.48%	Vanguard Fiduciary Trust Company	127,761	US$780.6k	-0.3%	no data
0.44%	Quantinno Capital Management LP	115,818	US$707.7k	52.5%	no data
0.43%	Two Sigma Investments, LP	114,167	US$697.6k	367%	no data
0.4%	Cresset Asset Management, LLC	106,349	US$649.8k	48.1%	no data
0.39%	The Goldman Sachs Group, Inc.	104,451	US$638.2k	23.4%	no data
0.39%	UBS Asset Management AG	103,810	US$634.3k	17.4%	no data
0.37%	BNP Paribas Financial Markets SNC	98,670	US$602.9k	57.6%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/26 08:53
End of Day Share Price	2026/05/26 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CVRx, Inc. is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
William Plovanic	Canaccord Genuity
Ross Osborn	Cantor Fitzgerald & Co.
Sarah James	Cantor Fitzgerald & Co.